Drug pricing and access to cancer medicines

The first Trump administration took several steps aimed at addressing high prescription drug prices, including the prices of cancer drugs. While there were no major policies specifically targeting cancer drugs, some of the broader initiatives were aimed at reducing drug costs and had a potential impact on oncology medications. In this interview, Gilberto de Lima Lopes (Sylvester Comprehensive Cancer at the University of Miami, FL, USA) provides an overview of key actions taken by the Trump administration in this area and what the ATOM coalition is working on to increase access to treatments for cancer. What key initiatives is the...